Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAurobindopharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Stay invested in Aurobindo Pharma, says Ashish Kyal

      Ashish Kyal of wavesstrategy.com is of the view that one may stay invested in Aurobindo Pharma.

    • Bull's Eye: Buy UPL, NELCO, IGL, Jet; sell SKS Micro

      Shahina Mukadam, Independent Market Expert advises buying Aurobindo Pharma with a target of Rs 750.

    • Positive on Aurobindo Pharma; sell BOI on bounce: Taparia

      Chandan Taparia of Anand Rathi Securities has a positive view on Aurobindo Pharma and advises selling Bank of India on bounce.

    • Buy Ajanta Pharma, prefer Jubilant Life: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Ajanta Pharma and prefers Jubilant Lifesciences.

    • Buy Eveready, Aurobindo Pharma: Rajat Bose

      Rajat Bose of rajatkbose.com recommends buying Eveready and Aurobindo Pharma.

    • Buy SBI, Tata Steel, Maruti, Pidilite, Voltas: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying State Bank of India, Tata Steel, Maruti Suzuki, Pidilite Industries and Voltas.

    • Buy Ajanta Pharma, Aurobindo Pharma, NCC: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Ajanta Pharma, Aurobindo Pharma and NCC.

    • Budget 2016: Sell Reliance Infra, Reliance Capital, Cummins India: Gujral

      Ashwani Gujral - Fund manager at ashwanigujral.com recommends selling Reliance Infrastructure, Reliance Capital and Cummins India.

    • Budget 2016: Buy SBI, HUL, SKS Microfinance, LIC Housing: Ashwani Gujral

      Ashwani Gujral - Fund manager at ashwanigujral.com recommends buying State Bank of India, Hindustan Unilever, SKS Microfinance and LIC Housing Finance.

    • Buy NTPC, IGL, L&T, HDFC Bank: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com advises buying NTPC, L&T and HDFC Bank.

    • Buy Sun Pharma, sell banking stocks: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Sun Pharma and feels that all banking stocks are sell ideas.

    • Sell Aurobindo Pharma, says Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends selling Aurobindo Pharma.

    • Sell Sun TV, Aurobindo Pharma; buy M&M: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can sell Sun TV Network and Aurobindo Pharma and advises buying Mahindra & Mahindra.

    • Sell Strides Shasun, Torrent Pharma, Aurobindo Pharma: Gujral

      Ashwani Gujral of ashwanigujral.com recommends selling Strides Shasun, Torrent Pharma and Aurobindo Pharma and feels that ITC may head lower and test Rs 260.

    • Sell ICICI Bank, HDFC Bank, BHEL; buy Cadila Health: Gujral

      Ashwani Gujral of ashwanigujral.com recommends selling ICICI Bank, HDFC Bank, BHEL and Voltas and advises buying Cadila Healthcare and Aurobindo Pharma.

    • Buy UltraTech, Biocon, CESC; sell Engineers India, OBC: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying UltraTech Cement, Biocon and CESC and advises selling Engineers India and OBC.

    • Sell BPCL; buy Ashok Leyland, Ceat, Hexaware: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can sell Bharat Petroleum Corporation and buy Ashok Leyland, Ceat and Hexaware Technologies.

    • Buy Sun Pharma, Cairn, Tata Steel, BoB, Torrent Pharma: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharma, Cairn India, Tata Steel, Bank of Baroda and Torrent Pharma.

    • Buy BPCL, Adani Port, Kotak Mahindra Bank: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may buy Adani Port, Aurobindo Pharma, BPCL, Torrent Pharma and Kotak Mahindra Bank.

    • Sell Aurobindo Pharma, Union Bank: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends selling Aurobindo Pharma and Union Bank.

    • Buy United Breweries, says Rajat Bose

      Rajat Bose of rajatkbose.com recommends buying United Breweries for a target of Rs 820.

    • Asian Paints may test Rs 866, HDFC Bank Rs 1010: Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that Asian Paints may test Rs 866 while HDFC Bank may hit Rs 1010.

    • Buy Aurobindo Pharma, BOI, Idea Cellular, Voltas: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Aurobindo Pharma, BOI, Idea Cellular, Voltas, LIC Housing and DHFL.

    • Like Aurobindo Pharma, Glenmark Pharma: SP Tulsian

      SP Tulsian of sptulsian.com likes Aurobindo Pharma and Glenmark Pharma.

    • Accumulate Aurobindo Pharma, advises Mayuresh Joshi

      Mayuresh Joshi of Angel Broking is of the view that one can accumulate Aurobindo Pharma.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347